Richard Hoffman
Fortune : 1 M $ au 30/06/2026
Fortune : 1 M $ au 30/06/2026
Richard A. Hoffman was the founder of TargetRx, Inc., founded in 1999, where the title held was Chief Executive Officer.
Mr. Hoffman currently works at Incyte Corp.
as Secretary, Executive VP & General Counsel since 2025.
Former jobs include Chief Executive Officer at Synglyco, Inc., Chief Business Officer at Ablexis LLC, and Partner at Goodwin Procter LLP.
Education history includes graduate degrees from The Trustees of Columbia University in The City of New York and Columbia Law School, an MBA from The Wharton School of the University of Pennsylvania, and an undergraduate degree from Harvard College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/12/2025 | 9 466 ( 0% ) | 1 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INCYTE CORPORATION | Conseiller Juridique Général | 01/12/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
Ablexis LLC
Ablexis LLC Packaged SoftwareTechnology Services Develops next-generation platform for antibody drug discovery | Corporate Officer/Principal | - |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Directeur Général | - |
TargetRx, Inc.
TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing consultancy services | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
TargetRx, Inc.
TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing consultancy services | Commercial Services |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Ablexis LLC
Ablexis LLC Packaged SoftwareTechnology Services Develops next-generation platform for antibody drug discovery | Technology Services |
Columbia Law School
Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national